老年头颈鳞癌根治性放疗后的生存模式
本研究分析2007至2014年674例接受根治性放疗(66-70 Gy)的头颈鳞癌患者,其中老年(≥70岁)168例。老年患者5年总生存和非癌性死亡率均显著差于年轻患者,但癌症特异性生存差异可忽略;年龄是总生存的独立预后因素,主要归因于非癌性死亡和合并症增加。
要点
- 老年患者5年总生存45.5% vs 年轻58.2%(P=.007),非癌性死亡39.0% vs 20.7%(P<.001)。
- 年龄是总生存独立预后因素,校正混杂后效应增强;癌症特异性生存差异可忽略。
- 老年患者放疗联合全身治疗与非癌性死亡风险显著相关(HR=8.02,95%CI 2.36-27.2,P=.001)。
核心结论
- 老年头颈鳞癌患者根治性放疗后总生存和非癌性死亡均差于年轻患者,但癌症特异性生存差异可忽略。
- 年龄是总生存的独立预后因素,主要归因于非癌性死亡和合并症增加。
研究设计与样本
- 采用多因素关联模型评估年龄对生存终点的影响,并多因素分析识别老年患者预后因素。
主要发现
- 老年患者5年总生存45.5% vs 年轻58.2%(P=.007),5年非癌性死亡率39.0% vs 20.7%(P<.001)。
- 老年患者中80例(47%)随访期间死亡,其中45%死于原发肿瘤。
- 老年患者总生存和癌症特异性生存的独立预后因素包括较差WHO体能状态、淋巴结受累和特定肿瘤部位。
关键数值与推荐
- 根治性放疗剂量66-70 Gy。
- 老年患者放疗联合全身治疗与非癌性死亡风险显著相关(HR=8.02,95%CI 2.36-27.2,P=.001)。
临床怎么用
- 老年头颈鳞癌患者根治性放疗决策需综合评估合并症和非癌性死亡风险。
- 对老年患者联合全身治疗时需警惕非癌性死亡风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We sought to assess the effect of age on overall survival (OS), cancer-specific survival (CSS), and non-cancer-related death (NCRD) in elderly (aged ≥70 years) head and neck squamous cell carcinoma (HNSCC) patients treated with definitive radiation therapy. The results were compared with those of younger patients, and the most important prognostic factors for survival endpoints were determined. Treatments may be better justified based on identification of the main differences in survival between young and elderly patients. METHODS AND MATERIALS: Data were analyzed from all consecutive HNSCC patients treated with definitive radiation therapy (66-70 Gy) in our department between April 2007 and December 2014. A total of 674 patients, including 168 elderly patients (24.9%), were included in the study. Multivariate association models were constructed to assess the effect of age on survival endpoints. Multivariate analysis was performed to identify potential prognostic factors for survival in elderly patients. RESULTS: A total of 674 consecutive patients, including 168 elderly patients, were analyzed. The 5-year OS and NCRD rates were significantly worse for elderly patients than for young patients: 45.5% versus 58.2% (P=.007) and 39.0% versus 20.7% (P<.001), respectively. In the multivariate association analysis on the relationship between age and OS, lymph node involvement and worse World Health Organization (WHO) performance status were identified as significant confounders. Multivariate association analysis between age and NCRD identified Union for International Cancer Control stage as a significant confounder. After correction for confounders, the effect of age on OS and NCRD increased. Worse WHO performance status, lymph node involvement, and specific tumor site were independent prognostic factors for OS and CSS in the elderly patient group. Of the elderly patients, 80 (47%) died during follow-up; 45% of these deaths were ascribed to the index tumor. For elderly patients, radiation therapy combined with systemic forms of treatment was significantly associated with adverse NCRD rate (hazard ratio, 8.02; 95% confidence interval, 2.36-27.2; P=.001) after we performed a multivariate association analysis. CONCLUSIONS: Elderly HNSCC patients have worse survival outcomes than young HNSCC patients. Age is an independent prognostic factor for OS, mainly due to an increase in non-cancer-related mortality and comorbid diseases. The differences in CSS between young and elderly patients are negligible.
引用
- Sommers LW, Steenbakkers RJHM, Bijl HP, et al. Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017. PMID: 28476434. doi:10.1016/j.ijrobp.2017.02.214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。